EU Institutions

2026 will be a pivotal year for Europe’s transition to a circular economy. The landmark Circular Economy Act will seek to create a coherent single market for secondary raw materials and reduce regulatory fragmentation across the EU, while the EU Water Resilience Strategy aims to accelerate...

In recent years, golden visa and citizenship-by-investment schemes have become a focal point in the debate over the intersection of economic growth, migration policy and EU integrity.   While such programmes have attracted billions of euros in investment to several Member States—most notably Greece, Portugal and Malta—they have also...

As Europe heads to a net-zero economy, renewable liquid gases (rLGs) such as bioLPG and renewable DME are gaining attention as practical, immediately deployable solutions for decarbonising transport, heating, and industrial sectors, particularly in rural and off-grid areas where energy...

The EU is a global leader in biotechnology, with the sector having expanded more than twice as fast as the overall economy in recent years. Yet, it faces significant challenges when it comes to scaling up EU-based production. Despite rapid advancements in biotech R&D, critical health products...

Menopause is a universal life stage, yet it remains largely invisible in policy debates—despite its far-reaching implications for health systems, labour markets, and gender equality. In the EU, rising life expectancy and rapid population ageing mean that more women will spend decades post-menopause,...

Europe is at a pivotal moment for its industrial base. The ongoing energy disruption combined with intensifying global competition and strategic dependencies, is reshaping how Europe powers its economy and sustains industrial strength. High energy costs, access to clean technologies, resilient supply chains, and skilled labour have become central to Europe’s competitiveness,...

Women’s health — and menopause in particular — is gaining increasing attention across Europe, as policymakers and healthcare experts recognise its significant impact on public health, workforce participation, and gender equality.  Building on previous discussions in the European Parliament, this flagship breakfast...

As legislators review the Biotech Act, they face a generational opportunity to strengthen Europe’s clinical trials landscape and its global competitiveness. The Commission’s proposal outlines changes that can help reverse Europe’s declining share in global clinical research, bridge the emerging...

Biotechnology is becoming a decisive capability for Europe’s competitiveness, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape, uneven regulatory capacity, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech...

Now in its 22nd edition, the MEP Awards celebrate the excellence, dedication, and impact of Members of the European Parliament (MEPs), their Assistants (APAs), and Parliament staff. As MEPs enter the second year of their mandate, this year’s gala dinner...